Alexander M. Gold
Director · Mineralys Therapeutics, Inc.
- 2025
- Feb 21, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Alexander M. Gold files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Taylor Slingsby - $46.36M in MLYS purchases and sales in the last 12 months
- Jon Congleton - $15.64M in MLYS purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $8.76M in MLYS purchases and sales in the last 12 months
- Adam Scott Levy - $5.36M in MLYS purchases and sales in the last 12 months
- David Malcom Rodman - $4.43M in MLYS purchases and sales in the last 12 months
- Eric Warren - $3.30M in MLYS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Alexander M. Gold?
Alexander M. Gold is a corporate insider, tracked as Director of Mineralys Therapeutics, Inc. (MLYS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Alexander M. Gold last file a Form 4?
The most recent primary Form 4 on record is dated 21 February 2026, one of 2 filings going back to 2025.
Has Alexander M. Gold been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($1.58M) across all tracked filings.
